Servier Medical

Servier worldwide

• Servier Research Group is France’s leading independent pharmaceutical company and the second French pharmaceutical company worldwide, with more than 22 000 employees, including close to 3000 in R&D;
• 23% of the revenue from brand-name medicines invested in R&D in 2019/2020;
• 30 new molecules under development in the following therapeutic areas: oncology, cardiology, diabetes, neuropsychiatry and immunoinflammatory diseases;
• 150 countries in which the Group’s medicines are distributed;
• 100 million of patients treated every day with Servier medicines;
• € 4.7 billion in revenue in 2019/2020.

Servier in Bulgaria

• Servier is present for 27years in Bulgaria, with a team of 100 people and 26 registered medicines;
• In the top 10 companies on the Bulgarian pharmaceutical market, leader in the treatment of cardio-vascular and metabolic diseases.